Header

UZH-Logo

Maintenance Infos

Feasibility of concomitant MitraClip and left atrial appendage occlusion


Kuwata, Shingo; Taramasso, Maurizio; Zuber, Michel; Suetsch, Gabor; Attinger-Toller, Adrian; Wicki, David; Maisano, Francesco; Nietlispach, Fabian (2017). Feasibility of concomitant MitraClip and left atrial appendage occlusion. EuroIntervention, 12(16):1940-1945.

Abstract

AIMS: The aim of our study is to report our single-centre experience with concomitant MitraClip (MC) and left atrial appendage occlusion (LAAO) and further to assess the feasibility, safety and short-term outcome of such an approach.
METHODS AND RESULTS: Twenty-five consecutive patients underwent MC with concomitant LAAO at our hospital (combined group). As a control group, 25 consecutive patients with atrial fibrillation (AF) undergoing standalone MC were selected. Baseline parameters were equal between the two groups. Patients in the combined group had longer procedural time (90.0 min vs. 66.0 min, p=0.02) and radiation time (32.0 min vs. 18.0 min, p=0.01). There were no procedural deaths. At 30 days, one patient died due to cerebral haemorrhage (combined vs.
CONTROL: 4% vs. 0%, p=0.32) and two had acute kidney injury (combined vs.
CONTROL: 4% vs. 4%, p=1.00). In multivariate analysis, the association of LAAO with device or procedural success was not significant.
CONCLUSIONS: LAAO along with MC in a single stage procedure is feasible. These preliminary results have to be validated in a large randomised study, in order to assess the efficacy of combined LAAO that can be expected to become evident only after longer follow-up.

Abstract

AIMS: The aim of our study is to report our single-centre experience with concomitant MitraClip (MC) and left atrial appendage occlusion (LAAO) and further to assess the feasibility, safety and short-term outcome of such an approach.
METHODS AND RESULTS: Twenty-five consecutive patients underwent MC with concomitant LAAO at our hospital (combined group). As a control group, 25 consecutive patients with atrial fibrillation (AF) undergoing standalone MC were selected. Baseline parameters were equal between the two groups. Patients in the combined group had longer procedural time (90.0 min vs. 66.0 min, p=0.02) and radiation time (32.0 min vs. 18.0 min, p=0.01). There were no procedural deaths. At 30 days, one patient died due to cerebral haemorrhage (combined vs.
CONTROL: 4% vs. 0%, p=0.32) and two had acute kidney injury (combined vs.
CONTROL: 4% vs. 4%, p=1.00). In multivariate analysis, the association of LAAO with device or procedural success was not significant.
CONCLUSIONS: LAAO along with MC in a single stage procedure is feasible. These preliminary results have to be validated in a large randomised study, in order to assess the efficacy of combined LAAO that can be expected to become evident only after longer follow-up.

Statistics

Citations

Dimensions.ai Metrics
2 citations in Web of Science®
2 citations in Scopus®
3 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 12 Dec 2017
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiovascular Surgery
04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:20 March 2017
Deposited On:12 Dec 2017 17:33
Last Modified:30 Mar 2018 05:44
Publisher:Europa Digital and Publishing
ISSN:1774-024X
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.4244/EIJ-D-16-00784
PubMed ID:28044988

Download